RNS Number : 2671I
Ampeak Energy Limited
20 November 2025
20 November 2025
AMPEAK ENERGY LIMITED
("Ampeak Energy" or the "Company")
CCR funding completed
Ampeak Energy is pleased to advise that it has received the final tranche of £3.5m of the £8.5m loan from Cardiff Capital Region ("CCR"), first announced on 16th April 2025.
The final payment was made following the receipt of planning permission, as announced on 1 October 2025, and the expiry of the Judicial Review period for the AW2 battery storage project.
Ampeak Energy will utilise these funds to further accelerate the delivery of its exciting pipeline of battery storage projects.
For further information, please contact:
Ampeak Energy Sean Parsons
+44 (0)7739832446
Strand Hanson Limited (Nominated and Financial Adviser) Richard Johnson Rory Murphy David Asquith
+44 (0)20 7409 3494
Zeus Capital Limited (Broker) Louisa Waddell Simon Johnson
+44 (0)20 3829 5000
Notes to Editors
Ampeak Energy is a global developer, owner and operator of sustainable energy projects. Ampeak Energy owns the world's flagship tidal stream project, MeyGen, and the Uskmouth Power Station site, which is being repurposed into a sustainable energy park that will become one of the UK's largest battery energy storage sites. www.ampeak.energy
Ampeak Energy's strategy: "Building a Sustainable Future to 2035", can be viewed here
Proud to be part of London's universe of Green Economy Equities
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCEAAFNFFESFAA
